Relationships between pharmacokinetics and nonpulmonary pharmacodynamic effects of theophylline.

Author: HenryJ A, HuseyinT S, MintonN A

Paper Details 
Original Abstract of the Article :
Concentration-effect relationships between oral theophylline and its nonpulmonary pharmacodynamic effects were examined in a double-blind, randomized, two-way crossover study in which 10 healthy subjects received a single dose of 500 mg ordinary-release theophylline or placebo. Mean plasma theophyll...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1038/clpt.1994.188

データ提供:米国国立医学図書館(NLM)

Theophylline: A Balancing Act Between Pharmacokinetics and Pharmacodynamics

The study delves into the intricate relationship between theophylline's pharmacokinetics (how the body processes the drug) and its pharmacodynamic effects (how the drug affects the body). The authors investigated the nonpulmonary effects of theophylline, examining its impact on various physiological parameters, such as blood pressure, potassium, and magnesium levels. Their findings highlight the complex interplay between pharmacokinetic and pharmacodynamic factors, emphasizing the importance of understanding these interactions for optimizing therapeutic outcomes.

Delay in the Desert: Understanding the Time Lag

The study observed a delay in the onset of theophylline's nonpulmonary pharmacodynamic effects, suggesting that the drug's actions are mediated by intracellular processes. This delay, known as negative hysteresis, highlights the need to consider not just the concentration of the drug in the bloodstream but also the time it takes for the drug to exert its effects. The researchers emphasize the importance of recognizing these discrepancies between pharmacokinetic and pharmacodynamic profiles to accurately assess the duration of action of a drug.

Navigating the Pharmacokinetic Desert: A Journey Through the Body

This study serves as a reminder that the human body is a complex and dynamic system. Understanding the intricate interplay between pharmacokinetics and pharmacodynamics is essential for navigating the desert of drug therapy. This research highlights the importance of considering individual patient characteristics and the nuances of drug metabolism when making treatment decisions.

Dr. Camel's Conclusion

This study showcases the complexities of drug therapy and the importance of understanding the interplay between pharmacokinetics and pharmacodynamics. Recognizing the potential for delays in drug action and the impact of intracellular processes is crucial for maximizing therapeutic benefits and minimizing potential side effects. As researchers continue to unravel the mysteries of drug metabolism and action, we can expect even more precise and personalized approaches to drug therapy in the future.

Date :
  1. Date Completed 1995-01-18
  2. Date Revised 2019-05-12
Further Info :

Pubmed ID

7995005

DOI: Digital Object Identifier

10.1038/clpt.1994.188

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.